MK
MKDTY.US Molecular Data Inc.
- Market cap
- USD 1.22K
- P/E
- -
- P/B
- 0.00x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 4 quarters up to Jun 2023.
Is MKDTY.US undervalued?
Graham numberThe Graham number of Molecular Data Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Molecular Data Inc. fundamental analysis
No fundamental analysis for Molecular Data Inc. yet.
Molecular Data Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Molecular Data Inc.
Molecular Data Inc., through its subsidiaries, operates in the chemical e-commerce business in the People's Republic of China. The company operates technology-driven platform that connects participants along the chemical value chain through its integrated solutions. It delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and software-as-a-service suites for participants in the traditional chemical industry. The company offers its e-commerc…
Full company profileMolecular Data Inc. financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 4 quarters up to Jun 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Molecular Data Inc. annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2023 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 3.21B | 4.20B | 9.05B | 13.2B | 7.60B | - |
| Gross Profit | 26.1M | 50.2M | 80.2M | 103M | -10.2M | - |
| Operating Income | -106M | -91.2M | -236M | -190M | -332M | - |
| EBITDA | -105M | -89.5M | -233M | -186M | -313M | - |
| Net Income | -114M | -108M | -255M | -194M | -328M | - |
| EPS | -15 | -14 | -33 | -28 | -42 | - |
| Balance Sheet | ||||||
| Total Assets | - | 381M | 372M | 372M | 685M | 746M |
| Total Liabilities | - | 375M | 433M | 433M | 713M | 681M |
| Shareholders' Equity | - | 5.90M | -61.6M | -61.6M | -27.9M | 64.3M |
| Cash & Short-term Investments | - | 38.5M | 6.48M | 6.48M | 347M | 402M |
| Total Debt | - | 139M | 82.0K | 82.0K | 71.1M | 75.5M |
| Cash Flow | ||||||
| Operating Cash Flow | -146M | -187M | -135M | -95.8M | -234M | -7.87M |
| Capital Expenditure | 2.65M | 1.93M | 2.24M | 1.82M | 116K | 930.62 |
| Free Cash Flow | -148M | -189M | -137M | -97.6M | -234M | -7.87M |
| Ratios | ||||||
| ROE | - | -1,826.9% | - | - | - | - |
| ROA | - | -28.3% | -68.5% | -52.1% | -47.9% | - |
| Net Profit Margin | -3.6% | -2.6% | -2.8% | -1.5% | -4.3% | - |
| Debt to Equity | - | 23.48x | - | - | - | 1.17x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Molecular Data Inc. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | CNY 6.81M | 0.89 | - |
| 2017 | CNY 370K | 0.05 | - |
| 2016 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:15 on May 23, 2022.
Who owns Molecular Data Inc.
- Insiders 0.00%
- Institutions 5.58%
- Public & others 94.42%
- Shares outstanding 12.2M
- Free float 8.91M
Molecular Data Inc. company profile
- Company name
- Molecular Data Inc.
- Ticker
- MKDTY.US
- Exchange
- USA Stocks
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 189
- Fiscal year end
- December
- Address
- Building 15, Shanghai, China, 201106
- Phone
- 86 21 5436 5166
- Website
- molbase.cn
About Molecular Data Inc.
Molecular Data Inc., through its subsidiaries, operates in the chemical e-commerce business in the People's Republic of China. The company operates technology-driven platform that connects participants along the chemical value chain through its integrated solutions. It delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and software-as-a-service suites for participants in the traditional chemical industry. The company offers its e-commerce solutions through online platform that consists of molbase.com and molbase.cn websites; Moku Data Weixin account; Chemical Community app; and other ancillary platforms. Molecular Data Inc. was founded in 2013 and is headquartered in Shanghai, the People's Republic of China.
Molecular Data Inc. management
3- Mr. Steven FooCEO & CFO · born 1972
- Dr. Dongliang ChangFounder & Chairman of Board of Directors · born 1975
- Mr. Jingming ZhongCompliance Officer